The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Newsletter July 2017
Overview of open calls for proposals for a growing portfolio, new partnerships, new clinical trials launched, African initiatives and new members of the Scientific Advisory Committee. Subscribe here.
EDCTP Update June
The EDCTP Update is published monthly in English. Subscribe here.
Picture of launch of IRESSEF, Senegal.
Annual Report 2016
“ EDCTP2 is a highly ambitious programme and 2016 was a transformational year for
consolidating the organisation itself and accelerating focused implementation of the programme. ”
Latest news
Independent observer assesses Scientific Review Committee meetings
To ensure the integrity of its evaluation procedures and to find ways to improve quality, efficiency and transparency, EDCTP recently…
EC Call for Tender: burden of diseases preventable by maternal immunisation in sub-Saharan Africa
The European Commission Directorate-General for Research and Innovation issued a call for tender on 14 July 2017 on the topic…